Thanks to its unique mode of action, tolerability and safety profile, Estetrol is expected to offer safer clinical use in a wide range of indications, far beyond women’s health.
To further explore Estetrol capabilities, Mithra plans to expand its R&D platform, particularly in the areas of neuroprotection, dermatology (e.g. wound healing) and cancers.